Ruibo’an® Posaconazole Injection

【Generic Name】
Posaconazole Injection 
【Indications】 
1. Treatment of Invasive Aspergillosis 
For the treatment of invasive aspergillosis in patients aged 13 years and older. 
2. Prevention of invasive aspergillosis and candidiasis 
It is indicated for children aged 2 years and older and for adults who are at increased risk of these infections due to severe immunodeficiency, such as patients who have developed graft-versus-host disease (GVHD) following hematopoietic stem cell transplantation (HSCT) or patients with hematologic malignancies who experience prolonged neutropenia as a result of chemotherapy. 
【Specification】 
16.7 ml: 0.3 g 
【National Drug Approval Number H20233490】
For more information, please refer to the instruction manual.